Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40401 | 0.82 | CHRM2 (0.69) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| SCHEMBL606716 | 0.80 | CHRM2 (0.55) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| Hydrochloric Acid SCHEMBL6065696 | 0.80 | CHRM2 (0.67) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| SCHEMBL6896147 | 0.78 | CHRM2 (0.53) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| SCHEMBL6784532 | 0.78 | ALDH1A1 (0.53) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| Hydrochloric Acid SCHEMBL23527967 | 0.78 | CHRM2 (0.53) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| SCHEMBL9995162 | 0.78 | CHRM2 (0.53) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| SCHEMBL24170552 | 0.78 | CHRM2 (0.53) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| SCHEMBL8014820 | 0.78 | CHRM2 (0.53) | CHRM2HPGDALDH1A1TAAR1KMT2A | |
| SCHEMBL15129253 | 0.78 | CHRM2 (0.53) | CHRM2HPGDALDH1A1TAAR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022000443-A1 | METHODS AND COMPOSITIONS FOR TARGETING TREGS USING CCR8 INHIBITORS | Nanjing Immunophage Biotech Co., Ltd. (CN) | 2022-01-06 | — | — | WO | disclosed |
| CN-107074866-B | Pyrimido-pyrrole compound, preparation method thereof, medicinal composition and application thereof | 厦门大学 | 2019-06-07 | — | — | CN | disclosed |
| EP-2632460-B1 | THIOPHENE DERIVATIVES FOR USE IN THE TREATMENT OF TUBERCULOSIS | UNIV VIRGINIA PATENT FOUNDATION (US) | 2018-02-28 | — | — | EP | disclosed |
| CN-107074866-A | Pyrimido-pyrrole compound, preparation method thereof, medicinal composition and application thereof | 厦门大学 | 2017-08-18 | — | — | CN | disclosed |
| CN-106188060-A | Pyrimido azoles, its preparation method, Pharmaceutical composition and application thereof | 厦门大学 | 2016-12-07 | — | — | CN | disclosed |
| CN-101400336-B | Novel flavoring agents, taste modifiers, tastants, taste enhancers, umami or sweeteners and/or enhancers and uses thereof | SENOMYX INC | 2013-06-05 | — | — | CN | disclosed |
| CN-101400336-A | Novel flavoring agents, taste modifiers, tastants, taste enhancers, umami or sweeteners and/or enhancers and uses thereof | SENOMYX INC (US) | 2009-04-01 | — | — | CN | disclosed |
| CN-101203142-A | Aromatic amides and ureas and their uses as sweet and/or delicate flavor modifiers, flavouring agents and taste enhancers | SENOMYX INC (US) | 2008-06-18 | — | — | CN | disclosed |
| US-7323464-B2 | Pyridine and pyrimidine derivatives | CELLTECH R&D LIMITED (GB) | 2008-01-29 | — | — | US | disclosed |
| CN-1301981-C | Medicinal composition containing 1,3-thiazine derivative | SHIONOGI & CO (JP) | 2007-02-28 | — | — | CN | disclosed |
| CN-1247553-C | 2-imino-1,3-thiazine derivs. | SHIONOGI & CO (JP) | 2006-03-29 | — | — | CN | disclosed |
| US-20050080258-A1 | Pyridine and pyrimidine derivatives | GENTEX CORPORATION | 2005-04-14 | — | — | US | disclosed |
| EP-1448555-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES | Celltech R & D Limited (GB) | 2004-08-25 | — | — | EP | disclosed |
| WO-2003045941-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES | CELLTECH R & D LIMITED (GB) | 2003-06-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080258-A1 | Pyridine and pyrimidine derivatives | ROR1, MAPK1, IRAK1 | CHRM2 861/4885HPGD 1994/4885ALDH1A1 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.